Close
MyNorthwest
News
Opinion
Sports
Tools
Connect

Researchers: Breast cancer drug could help more patients

This undated photo provided by Daiichi Sankyo and AstraZeneca in June 2022 shows a vial and packaging for their Enhertu, an antibody-chemotherapy drug administered intravenously. (Daiichi Sankyo/AstraZeneca via AP) This undated photo provided by Daiichi Sankyo and AstraZeneca in June 2022 shows production of their Enhertu, an antibody-chemotherapy drug administered intravenously. (Daiichi Sankyo/AstraZeneca via AP) This undated photo provided by Daiichi Sankyo and AstraZeneca in June 2022 shows production of their Enhertu, an antibody-chemotherapy drug administered intravenously. (Daiichi Sankyo/AstraZeneca via AP) This undated photo provided by Daiichi Sankyo and AstraZeneca in June 2022 shows a vial and packaging for their Enhertu, an antibody-chemotherapy drug administered intravenously. (Daiichi Sankyo/AstraZeneca via AP)
Researchers: Breast cancer drug could help more patients